Chromane amidine monobactam antibiotics
AssigneeMerck Sharp & Dohme Corp.
InventorsHelen Y. Chen, Shuzhi Dong, Zhiyong Hu, Jing Su, Tao Yu, Yong Zhang
Life of this patent
Estimating the term…
Loading patent…
AssigneeMerck Sharp & Dohme Corp.
InventorsHelen Y. Chen, Shuzhi Dong, Zhiyong Hu, Jing Su, Tao Yu, Yong Zhang
Estimating the term…
The present invention relates to monobactam compounds of Formula I: The present invention also relates to pharmaceutical compositions comprising a monobactam compound of structural formula I or a pharmaceutically acceptable salt thereof. The invention further relates to the compounds of formula (I) for use in methods for treating a bacterial infection, either alone or in combination with a therapeutically effective amount of a second beta-lactam antibiotic. The present invention discloses the synthesis and characterisation of exemplary compounds as well as biological assays thereof. An exemplary compound is e.g.(S)-2-((((Z)-1-(2-aminothiazol-4-yl)-2-(((S)-2,2-dimethyl-4-oxo-1-(sulfooxy)azetidin-3-yl)amino)-2- oxoethylidene)amino)oxy)-2-((R)-6-(N—((S)-pyrrolidin-3-yl) carbamimidoyl)chroman-2-yl)propanoic acid (example 7; compound 1):
1-18. (canceled)
A pharmaceutical composition comprising a therapeutically effective amount of a compound selected from:
A pharmaceutical composition comprising a therapeutically effective amount of a compound selected from:
21-31. (canceled)
Dependencies are inferred from the claim text.